These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 25197661)
1. Clonotypic analysis of immunoglobulin heavy chain sequences in patients with Waldenström's macroglobulinemia: correlation with MYD88 L265P somatic mutation status, clinical features, and outcome. Petrikkos L; Kyrtsonis MC; Roumelioti M; Georgiou G; Efthymiou A; Tzenou T; Panayiotidis P Biomed Res Int; 2014; 2014():809103. PubMed ID: 25197661 [TBL] [Abstract][Full Text] [Related]
2. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768 [TBL] [Abstract][Full Text] [Related]
3. Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM. Wang J; Yan Y; Xiong W; Song G; Wang Y; Zhao J; Jia Y; Li C; Yu Z; Yu Y; Chen J; Jiao Y; Wang T; Lyu R; Li Q; Ma Y; Liu W; Zou D; An G; Sun Q; Wang H; Xiao Z; Wang J; Qiu L; Yi S Blood Adv; 2022 Jul; 6(13):4049-4059. PubMed ID: 35537114 [TBL] [Abstract][Full Text] [Related]
4. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Varettoni M; Arcaini L; Zibellini S; Boveri E; Rattotti S; Riboni R; Corso A; Orlandi E; Bonfichi M; Gotti M; Pascutto C; Mangiacavalli S; Croci G; Fiaccadori V; Morello L; Guerrera ML; Paulli M; Cazzola M Blood; 2013 Mar; 121(13):2522-8. PubMed ID: 23355535 [TBL] [Abstract][Full Text] [Related]
6. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Xu L; Hunter ZR; Yang G; Zhou Y; Cao Y; Liu X; Morra E; Trojani A; Greco A; Arcaini L; Varettoni M; Brown JR; Tai YT; Anderson KC; Munshi NC; Patterson CJ; Manning RJ; Tripsas CK; Lindeman NI; Treon SP Blood; 2013 Mar; 121(11):2051-8. PubMed ID: 23321251 [TBL] [Abstract][Full Text] [Related]
7. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia. Jiménez C; Sebastián E; Chillón MC; Giraldo P; Mariano Hernández J; Escalante F; González-López TJ; Aguilera C; de Coca AG; Murillo I; Alcoceba M; Balanzategui A; Sarasquete ME; Corral R; Marín LA; Paiva B; Ocio EM; Gutiérrez NC; González M; San Miguel JF; García-Sanz R Leukemia; 2013 Aug; 27(8):1722-8. PubMed ID: 23446312 [TBL] [Abstract][Full Text] [Related]
8. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease. Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994 [TBL] [Abstract][Full Text] [Related]
9. L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma. Mori N; Ohwashi M; Yoshinaga K; Mitsuhashi K; Tanaka N; Teramura M; Okada M; Shiseki M; Tanaka J; Motoji T PLoS One; 2013; 8(11):e80088. PubMed ID: 24224040 [TBL] [Abstract][Full Text] [Related]
11. Detection of MYD88 L265P in peripheral blood of patients with Waldenström's Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. Xu L; Hunter ZR; Yang G; Cao Y; Liu X; Manning R; Tripsas C; Chen J; Patterson CJ; Kluk M; Kanan S; Castillo J; Lindeman N; Treon SP Leukemia; 2014 Aug; 28(8):1698-704. PubMed ID: 24509637 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences. Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080 [TBL] [Abstract][Full Text] [Related]
13. Detection of the MYD88 Wu YY; Jia MN; Cai H; Qiu Y; Zhou DB; Li J; Cao XX Ann Hematol; 2020 Aug; 99(8):1763-1769. PubMed ID: 32577844 [TBL] [Abstract][Full Text] [Related]
14. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report. Barnes M; Sharma P; Kumar V; Kaell A; LiPera W J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665 [TBL] [Abstract][Full Text] [Related]
15. [Clonotypic analysis of immunoglobulin heavy chain sequences among 44 patients with Waldenström macroglobulinemia]. Tang J; Xia Y; Yin H; Wang L; Wu J; Chen R; Liang J; Zhu H; Fan L; Li J; Xu W Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Mar; 40(3):263-268. PubMed ID: 36854398 [TBL] [Abstract][Full Text] [Related]
16. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations. King RL; Gonsalves WI; Ansell SM; Greipp PT; Frederick LA; Viswanatha DS; He R; Kyle RA; Gertz MA; Kapoor P; Morice WG; Howard MT Am J Clin Pathol; 2016 Jun; 145(6):843-51. PubMed ID: 27329639 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of Waldenström Macroglobulinemia in Korean Patients According to Mutational Status of MYD88 and CXCR4: Analysis Using Ultra-Deep Sequencing. Shin DW; Kim SM; Kim JA; Park HS; Hwang SM; Im K; Kim S; Kim J; Kwon S; Yoon SS; Lee DS Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e496-e505. PubMed ID: 31221512 [TBL] [Abstract][Full Text] [Related]
18. Rare Circulating Cells in Familial Waldenström Macroglobulinemia Displaying the MYD88 L265P Mutation Are Enriched by Epstein-Barr Virus Immortalization. Pertesi M; Galia P; Nazaret N; Vallée M; Garderet L; Leleu X; Avet-Loiseau H; Foll M; Byrnes G; Lachuer J; McKay JD; Dumontet C PLoS One; 2015; 10(9):e0136505. PubMed ID: 26352266 [TBL] [Abstract][Full Text] [Related]
19. Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors. Varettoni M; Zibellini S; Capello D; Arcaini L; Rossi D; Pascutto C; Rattotti S; Mangiacavalli S; Pochintesta L; Gotti M; Gaidano G; Cazzola M Leuk Lymphoma; 2013 Nov; 54(11):2485-9. PubMed ID: 23442064 [TBL] [Abstract][Full Text] [Related]
20. MYD88 L265P mutations are correlated with 6q deletion in Korean patients with Waldenström macroglobulinemia. Kim JA; Im K; Park SN; Kwon J; Choi Q; Hwang SM; Sekiguchi N; Yoon SS; Lee DS; Kim SY Biomed Res Int; 2014; 2014():363540. PubMed ID: 24895570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]